Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · AKUMS

AKUMS

HealthcarePharmaceuticals & Biotechnology₹10964 cr market cap
₹712.85 ▼ -0.46% today As of 19 Nov 2026
52-week low ₹414.0552-week high ₹823.30

-13.0% from the 52-week high · +73.0% above the low

Akums Drugs & Pharmaceuticals Ltd manufactures and distributes pharmaceutical products including injectables, generics, and hospital supplies. The company ensures high-quality standards and regulatory compliance.

The short version. AKUMS reported revenue of ₹1,342 crore for Sep 2026, up 31.8% from a year earlier. Net profit was ₹113 crore (up 175.6% year on year). Return on equity was 7.7% in Mar 2026. Promoter holding was 75.26% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

AKUMS trades 13.0% below its 52-week high and 73.0% above its 52-week low.

Change over period: —

1M+0.9%
3M-4.9%
6M+39.1%
1Y+66.4%

2 · The business

Is it growing?

Sales, year on year+31.8%

Sep 2026 revenue of ₹1,342 cr.

Profit, year on year+175.6%

Sep 2026 net profit of ₹113 cr.

Net margin8.4%

4.4 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue13421167115811601018102410561010
Net profit1131008566416314865
Net margin %8.48.67.35.74.06.214.06.5
EPS (₹)7.176.355.384.212.594.039.384.14

Annual

FY2026FY2025
Revenue43594118
Net profit255338
Net margin %5.98.2
EPS (₹)16.2121.49

3 · The quality

How well does it turn capital into profit?

Return on equity was 7.7% in Mar 2026; debt to equity is 0.02.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %7.711.1
Return on capital %10.911.8
EBITDA margin %14.112.8
Net margin %5.78.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.02
Interest cover5.1x
Current ratio3.25
P/E ratio30.3

4 · The owners

Who holds it, and are they adding?

Promoter holding75.26%

Unchanged over 8 quarters.

Foreign institutions4.5%

Down 1.86 pts over 8 quarters.

Domestic institutions11.08%

Up 4.08 pts over 8 quarters.

Mutual fund schemes23

+4 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter75.2675.2675.2675.2675.2675.2675.2675.260.0
FII6.365.774.242.281.151.371.914.5-1.86
DII7.07.48.859.2814.414.3513.4411.08+4.08
Public8.658.858.9310.466.466.296.666.43-2.22

Mutual fund holdings · Oct 2026

23 schemes hold this stock

19 the month before.

  • Old Bridge Flexi Cap Fund2.35% of NAV
  • Franklin India Opportunities Fund2.02% of NAV
  • Templeton India Value Fund1.83% of NAV
  • ICICI Prudential Healthcare Fund1.65% of NAV
  • Franklin India Multi Cap Fund1.56% of NAV
  • Franklin India Small Cap Fund1.16% of NAV
  • SAMCO SPECIAL OPPORTUNITIES FUND1.12% of NAV
  • NIPPON INDIA PHARMA FUND1.09% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for AKUMS are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about AKUMS

What is the AKUMS share price?

AKUMS (AKUMS) last closed at ₹712.85, down 0.46% on the day. Its 52-week range is ₹414.05 to ₹823.30.

What is the market cap of AKUMS?

AKUMS has a market capitalisation of about ₹10,964 crore. Its price-to-earnings ratio is 30.3.

How are AKUMS's latest results?

AKUMS reported revenue of ₹1,342 crore for Sep 2026, up 31.8% from a year earlier. Net profit was ₹113 crore (up 175.6% year on year). Return on equity was 7.7% in Mar 2026. Promoter holding was 75.26% in Sep 2026, up 0.00 points over 8 quarters.

Who owns AKUMS?

As of Sep 2026, shareholding was: Promoter 75.26%, FII 4.5%, DII 11.08%, Public 6.43%.

How many mutual funds hold AKUMS?

23 mutual fund schemes held AKUMS in October 2026. That compares with 19 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 03 Jul 2026 · Final Dividend - Rs. 1
  • 03 Jul 2026 · Special Dividend - Rs. 2

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.